Mantle-Cell
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002) (NCT01244009) | Tesaro, Inc. | 2010-12-01 |
| CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma (NCT00924326) | National Cancer Institute (NCI) | 2009-02-17 |
Track Mantle-Cell automatically
Every clearance here is in the API, with alerts when new ones post.